IRIS
CISTERNINO, MARIANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.260
EU - Europa 3.202
AS - Asia 2.166
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
SA - Sud America 3
AF - Africa 2
Totale 9.644
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.208
CN - Cina 2.125
UA - Ucraina 818
IE - Irlanda 708
SE - Svezia 432
FI - Finlandia 428
DE - Germania 414
IT - Italia 177
GB - Regno Unito 135
CA - Canada 49
FR - Francia 35
BE - Belgio 16
ES - Italia 11
IN - India 10
PL - Polonia 8
EU - Europa 6
KR - Corea 6
SG - Singapore 6
JO - Giordania 5
NL - Olanda 5
RU - Federazione Russa 5
AU - Australia 4
JP - Giappone 4
MX - Messico 3
TR - Turchia 3
BG - Bulgaria 2
BR - Brasile 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
IL - Israele 2
LK - Sri Lanka 2
MU - Mauritius 2
CL - Cile 1
EE - Estonia 1
GR - Grecia 1
HK - Hong Kong 1
IR - Iran 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
RO - Romania 1
TH - Thailandia 1
Totale 9.644
Salva come PNG Salva come JPEG
Città #
Chandler 1.014
Jacksonville 1.013
Dublin 708
Nanjing 681
Nanchang 270
Ashburn 250
Princeton 205
Shenyang 193
Lawrence 188
Hebei 183
Wilmington 177
Changsha 165
Jiaxing 159
Medford 132
Beijing 115
Tianjin 115
Boardman 109
Ann Arbor 93
Hangzhou 92
Woodbridge 62
Helsinki 50
Toronto 45
Norwalk 36
Falls Church 33
Milan 29
New York 27
Dearborn 21
Shanghai 21
Kunming 20
Houston 15
Seattle 15
Brussels 14
Des Moines 14
Jinan 14
Ningbo 12
Verona 12
Fairfield 10
Los Angeles 10
Taizhou 10
A Coruña 8
Padova 8
Radomsko 7
Washington 7
Zhengzhou 7
Borås 6
Fuzhou 6
Guangzhou 6
Pune 6
Amman 5
Lanzhou 5
Auburn Hills 4
Chicago 4
Leawood 4
Livorno 4
Rome 4
Turin 4
Changchun 3
Florence 3
Haikou 3
Orange 3
Palermo 3
Walnut 3
Zapopan 3
Ancona 2
Barcelona 2
Canberra 2
Cernusco sul Naviglio 2
Colombo 2
Haifa 2
Ixelles-Elsene 2
Monmouth Junction 2
North Bergen 2
Novokuznetsk 2
Omaha 2
Rockville 2
Sacramento 2
San Giuliano Milanese 2
Sofia 2
Stockholm 2
São Paulo 2
Sèvres 2
Tappahannock 2
Taranto 2
Torino 2
Aarau 1
Alba 1
Almere Stad 1
Andover 1
Ardabil 1
Arese 1
Bari 1
Barletta 1
Berlin 1
Bloomfield 1
Brescia 1
Brisbane 1
Buffalo 1
Busto Arsizio 1
Carol Stream 1
Casalecchio di Reno 1
Totale 6.506
Salva come PNG Salva come JPEG
Nome #
La sindrome oro-digito facciale tipo II. Studio clinico e cefalometrico di un caso 156
Central regulation of nasal cycle and magnetic resonance imaging of the brain in patients with Kallmann's syndrome 90
Role of Breast Ultrasonography in the Diagnosis of Precocious Puberty 81
Coagulation-factor deficiencies and abnormal bleeding in Noonan’s syndrome 80
A novel nonsense mutation in the Pit-1 gene: evidence for a gene dosage effect. 79
Gonadal function in adolescents receiving different conditioning regimens for bone marrow transplantation. 77
Severe hyponatremia followed by extrapontine myelinolysis 77
Hyperthyroidism in children 76
Cytotoxic activity in GH-deficiency 75
Influence of growth hormone (GH) on natural killer (NK) activity in women with impaired endogenous growth hormone secretion 73
Transdermal estradiol substitution therapy for the induction of puberty in female hypogonadism 72
Correlazione clinica tra taurodontismo e sindrome di Klinefelter 72
Long term growth hormone (GH)-releasing hormone and biosynthetic GH therapy in GH-deficient children: comparison of therapeutic effectiveness 71
Androgen insensitivity syndrome (AIS): a histologic and morphometric study in prepubertal patients 71
SHOX region mutation in Leri-Weill dischondrosteosis (LWS) 71
Analysis of the factor affecting auxological response to GnRH agonist treatment and final height outcome in girls with idiopathic central precocious puberty. 70
Mutational analysis in a group of patients with Noonan syndrome, new mutations identified in SOS1 70
Deficienze ed eccedenze ponderali 69
Multicenter Study On Prevalence of Endocrine Complications In Thalassemia Major - Italian Working Group On Endocrine Complications In Non-endocrine Diseases 68
Increased insulin response to intravenous glucose tolerance test in girls with central precocious puberty 68
Auxologia 68
Cyproterone acetate treatment in precocious puberty 68
Pubertal development after bone marrow transplantation in adolescents. 67
Linear growth according to the genotype of patients with Noonan syndrome 67
Cisti ovariche dall'epoca fetale all'adolescenza 66
Prospective study of endocrine side-effects following bone marrow transplantation in childhood. 65
Blood cell mitochondrial DNA content and premature ovarian aging 65
Biological activities of GH measured by Nb2 cell bioassay 65
Deficienze ed eccedenze staturali 64
Effect of corticoid therapy on growth hormone secretion 63
Abnormal growth in Noonan syndrome: correlation between growth parameters and genotype 63
Androgen insensivity syndrome (AIS): an histologic and morphometric study in prepubertal patients 63
Plasma leptin and its relationship with hormonal and metabolic parameters in girls with different forms of precocious puberty. 62
Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment. 62
Plasma IGF-I, IGFII, IGFBPs and their relationship with urinary Gh excretion and growth in thalassemia major patients 62
Final height attainment and gonadal function in girls with precocious puberty treated with cyproterone acetate 61
La pubertà precoce: aspetti diagnostici e terapeutici 60
Idiopathic central precocious puberty associated with 11 mb de novo distal deletion of the chromosome 9 short arm. 60
Adult height in children with short stature and idiopathic delayed puberty after different management. 60
McCune-Albright syndrome: a longitudinal clinical study of 32 patients 59
Adrenarche in patients with central precocious puberty: Influence on growth parameters before and during GnRH-Analog therapy 59
Growth hormone evaluation in short and tall children: assay-dependent results 59
Auxological, clinical and neuroradiological findings in infants with early onset growth hormone deficiency. 59
Factors influencing final/near-final height in 12 boys with central precocious puberty treated with gonadotrophin-releasing hormone agonists. Italian Study Group of Physiopathology of Puberty. 58
Alterazioni dello sviluppo puberale 58
Un caso familiare di sindrome di Noonan 58
Transdermal Estradiol Substitution Therapy For Female Hypogonadism In Thalassemia Major 58
Hormonal replacement therapy with HCG and HU-FSH in thalassaemic patients affected by hypogonadotropic hypogonadism. 58
Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. 57
La ragazza con sindrome di Turner che diventa adulta 57
Transdermal estradiol in female hypogonadism replacement therapy 57
Final height of patients with constitutional delay in growth and puberty (CDGP) with or without transient GH deficiency. 57
Effect of biosynthetic methionyl growth hormone (GH) therapy on the immune function in GH-deficient children 57
Growth and growth hormone deficiency in hypogonadotropic hypogonadism and hypo/anosmia (Kallmann's syndrome) 56
Magnetic resonance imaging (MRI) in 28 infants with GH deficiency presenting before five years of age (EGHD) 56
A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure. 56
Effectiveness of growth hormone (GH) therapy in GH-deficient children and non-GH-deficient short children 55
End results in central precocious puberty with GnRH analog treatment: the data of the italian study group for physiopathology of puberty. 55
Il trattamento della sindrome dell'ovaio policistico (PCOs) in età adolescenziale 55
Influence of biosynthetic growth hormone (GH) therapy on the immune system of GH-deficient children 55
Final height (FH) in 77 patients af fected by constitutional delay of growth and puberty (CDGP) variously treated 55
Etiology and age incident of precocious puberty in girls: a multicenter study. 54
Linear growth according to the genotype of patients with Noonan syndrome 54
L'abuso sessuale nei bambini prepuberi. Requisiti e raccomandazioni per una valutazione appropriata 54
Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty. 54
Comparison of bioactivity versus immunoactivity of serum growth hormone in children with growth disorders 54
Pharmachological Stimuli in the Diagnosis of Growth Hormone Deficiency: Pretreatment with Pyridostigmine 54
L’impiego dela formulazione trimestrale di leuprorelina (11,25 mg) nel trattamento della pubertà precoce vera 54
Growth in pubertal children after bone marrow transplantation 53
Recombinant growth hormone treatment in short patients with thalassemia major: results after 24 and 36 months. 53
Gonadal Function in adolescents after bone marrow transplantation 53
Patologie peculiari dell’apparato genitale 53
Growth promoting effect of long-term HCG and HU-FSH treatment in patients with hypogonadotropic hypogonadism 53
The influence of adrenarche on bone age and final height prediction of patients with central precocious puberty before and during GnRH analog therapy 53
Benzydamine for the topical treatment of vulvovaginitis in children and adolescents. 53
Selecting girls with precocious puberty for brain imaging: Validation of European evidence-based diagnosis rule 53
Etiology of central precocious puberty in males: the results of the italian study group for physiopathology of puberty. 52
Pharmacological stimuli in diagnosis of growth hormone deficiency: pretreatment with pyridostigmine 52
Recurrent abdominal pain and primary amenorrhea in an adolescent with plurimalformative syndrome 52
Induction of puberty with transdermal estradiol replacement therapy 52
Nk activity in GH deficiet children 52
Le precocità sessuali 52
Cryptic chromosomal deletions detected by array-CGH in four cases affected by central precocious puberty and neurodevelopmental disorders 52
The influence of parental origin of the extra X-chromosome on the somatic and neuro-behavioral(cognitive phenotype in a cohort of patients with Klinefelter sindrome. 52
L’infezione da Helicobacter Pylori in età pediatrica sembra favorire l’insorgenza di tiroiditi autoimmuni in soggetti HLA-DRB1*0301 positivi. 52
Dissection of partial 21q monosomy in different phenotypes: clinical and molecular characterization of five cases and review of the literature 52
Role of magnetic resonance imaging in the diagnosis and prognosis of growth hormone deficiency 51
The influence of parental origin of the extra X-chromosome on the somatic and neuro-behavioral/cognitive phenotype in a cohort of patients with Klinefelter syndrome 51
Final height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty. 51
Serum Anti-Müllerian Hormone (AMH) and Inhibin (IB) levels in girls with isolated premature thelarche and with central precocious puberty 51
Long-term follow-up of premature thelarche (PT) 51
Natural cytotoxicity and growth hormone treatment 51
Molecular genetic analysis of 21-OH mutated HLA haplotypes in disorders of puberty 51
Effect of HCG on growth velocity and biological growth parameters in adolescents with thalassemia major 51
Reduced bone mineral density in patients with thalassemia major:comparison between spontaneous and hormonally induced puberty 51
Long-term auxological response to gonadotropin releasing hormone agonist treatment and adult height in girls with idiopathic central precocious puberty 51
Inhibiting effect of GHRH 1-29 on natural cytotoxic activity 51
Immunological and endocrinological response to growth hormone therapy in short children 50
Treatment of central precocious puberty, comparison between the leuprorelin 1-month (3.75 mg) and 3-month depot (11.25 mg) formulations 50
Comparison between short acting and long acting tratment for CPP: Final data 50
Totale 6.064
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.362
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201915 0 0 0 0 0 0 0 0 0 0 5 10
2019/20202.724 751 1.132 11 151 10 181 12 176 5 221 66 8
2020/20211.555 176 139 62 153 7 213 3 205 64 246 225 62
2021/2022811 4 4 49 3 22 63 20 47 47 18 140 394
2022/20232.523 286 125 11 303 323 320 3 152 893 9 51 47
2023/2024663 90 118 19 75 79 178 5 74 4 21 0 0
Totale 9.685